Canaccord Genuity Maintains a 'Buy' on Auxilium Pharmaceuticals (AUXL); Meeting With CEO

May 29, 2012 8:20 AM EDT Send to a Friend
Canaccord Genuity maintains a 'Buy' on Auxilium Pharmaceuticals (NASDAQ: AUXL) price target of $27.00.

Analyst, Salveen Richter, said, "We ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login